Avoiding statin myopathy: understanding key drug interactions
Author:
Affiliation:
1. Emory University, Department of Medicine, 49 Jesse Hill Junior Drive, Atlanta, GA 30303, USA
2. 2Emory University, Office of Health Promotion & Disease Prevention, 49 Jesse Hill Junior Drive, Atlanta, GA 30303, USA
Publisher
Informa UK Limited
Subject
Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism
Link
https://www.tandfonline.com/doi/pdf/10.2217/clp.11.57
Reference58 articles.
1. Pasternak RC, Smith SC Jr, Bairey-Merz CN et al. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. Circulation 106, 1024–1028 (2002)
2. Bruckert E, Hayem G, Dejager S, Yau C,Begaud B. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients–the PRIMO study. Cardiovasc. Drugs Ther. 19, 403–414 (2005)
3. Sacks FM. Adherence to statin therapy: why aren’t we doing better? Am. J. Med. 113, 685–686 (2002)
4. Bouchard M-H, Dragomir A, Blais L, Berard A, Pilon D, Perreault S. Impact of adherence to statins on coronary artery disease in primary prevention. Br. J. Clin. Pharmacol. 63, 698–708 (2007)
5. Brewer HB Jr. Benefit-risk assessment of Rosuvastatin 10 to 40 milligrams. Am. J. Cardiol. 92, K23–K29 (2003)
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Drug–Drug Interactions in Nosocomial Infections: An Updated Review for Clinicians;Pharmaceutics;2024-08-28
2. Exploring the Effects of Short-Term Daily Intake of Nitraria retusa Tea on Lipid Profile: A Pre-Post, Uncontrolled Pilot Study in Both Healthy and Overweight/Obese Adults;Nutrients;2023-08-20
3. Effect of Roxadustat on the Pharmacokinetics of Simvastatin, Rosuvastatin, and Atorvastatin in Healthy Subjects: Results From 3 Phase 1, Open‐Label, 1‐Sequence, Crossover Studies;Clinical Pharmacology in Drug Development;2022-02-19
4. Pharmacology of Statins;Contemporary Cardiology;2020-12-16
5. Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions;Pharmacological Research;2020-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3